Young-Onset Colorectal Cancer

Plain-language summary

This study researches young-onset colorectal cancer by collecting biological specimens and information from patients and their family members. It enrolled patients diagnosed with colon or rectal cancer between ages 18-50 (or 51-80) and their first-degree relatives. It is being conducted as a study without a phase; it is not currently recruiting but is still ongoing (active, not recruiting).

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

M.D. Anderson Cancer Center

Intervention

Biospecimen Collection, Medical Chart Review, Quality-of-Life Assessment, Questionnaire Administration

Start date

6/7/2012

Estimated completion

8/31/2030

Countries

United States

Related genes

Locations

• Conroe, United States
• Houston, United States
• Houston, United States
• League City, United States
• Sugar Land, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* PATIENTS: MDACC patients who have adenocarcinoma of the colon or rectum, diagnosed between ages 18 through 50 (young-onset), or diagnosed at age 51 through 80 (later-onset)
* PATIENTS: Patient must have sufficient command of the English language and mental capacity to provide consent
* FAMILY MEMBERS: Be a parent, sibling or child (first degree blood relative) of a registered MDACC patient meeting eligibility criteria above
* FAMILY MEMBERS: Have sufficient command of the English language and mental capacity to provide consent
* FAMILY MEMBERS: Family member must be at least 18 years of age at the time of study registration